Thermo Fisher Scientific and Milu Labs will jointly develop a clinical mass spectrometry-based proteomics assay to evaluate pregnancy biomarkers and determine adverse pregnancy outcome risk among women in China.
Thermo Fisher partners with Milu Labs for mass spec assay
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.